Canaan IX L.P., Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 45,324 shares at $11.50 ($526K) on 2016-11-17, disclosed to the SEC on 2016-11-21.
Open-market sale of $526k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.50 | 18,971 | $218K | 41.5% |
| 2 | $11.64 | 12,805 | $149K | 28.3% |
| 3 | $11.72 | 13,548 | $159K | 30.2% |
| Total | $11.61 avg | 45,324 | $526K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-14 | $1.9M | — | Filing → |
| CTMX | SELL | 2016-06-10 | $487K | — | Filing → |